Literature DB >> 25303853

High prevalence of complementary and alternative medicine use in patients with genetically proven mitochondrial disorders.

Sebastian Franik1, Hidde H Huidekoper, Gepke Visser, Maaike de Vries, Lonneke de Boer, Marion Hermans-Peters, Richard Rodenburg, Chris Verhaak, Arine M Vlieger, Jan A M Smeitink, Mirian C H Janssen, Saskia B Wortmann.   

Abstract

Despite major advances in understanding the pathophysiology of mitochondrial diseases, clinical management of these conditions remains largely supportive, and no effective treatment is available. We therefore assumed that the burden of disease combined with the lack of adequate treatment leaves open a big market for complementary and alternative medicine use. The objective of this study was to evaluate the use and perceived effectiveness of complementary and alternative medicine in children and adults with genetically proven mitochondrial disease. The reported use was surprisingly high, with 88% of children and 91% of adults having used some kind of complementary and alternative medicine in the last 2 years. Also, the mean cost of these treatments was impressive, being <euro>489/year for children and <euro>359/year for adult patients. Over-the-counter remedies (e.g., food supplements, homeopathy) and self-help techniques (e.g., Reiki, yoga) were the most frequently used complementary and alternative therapies in our cohort: 54% of children and 60% of adults reported the various complementary and alternative medicine therapies to be effective. Given the fact that currently no effective treatment exists, further research toward the different therapies is needed, as our study clearly demonstrates that such therapies are highly sought after by affected patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25303853     DOI: 10.1007/s10545-014-9773-9

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  17 in total

Review 1.  Monogenic mitochondrial disorders.

Authors:  Werner J H Koopman; Peter H G M Willems; Jan A M Smeitink
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

2.  Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q).

Authors:  Sara A Quandt; Marja J Verhoef; Thomas A Arcury; George T Lewith; Aslak Steinsbekk; Agnete E Kristoffersen; Dietlind L Wahner-Roedler; Vinjar Fønnebø
Journal:  J Altern Complement Med       Date:  2009-04       Impact factor: 2.579

Review 3.  The clinical maze of mitochondrial neurology.

Authors:  Salvatore DiMauro; Eric A Schon; Valerio Carelli; Michio Hirano
Journal:  Nat Rev Neurol       Date:  2013-07-09       Impact factor: 42.937

4.  High prevalence of complementary and alternative medicine use in the Dutch pediatric oncology population: a multicenter survey.

Authors:  Maartje Singendonk; Gert-Jan Kaspers; Marianne Naafs-Wilstra; Antoinette Schouten-van Meeteren; Jan Loeffen; Arine Vlieger
Journal:  Eur J Pediatr       Date:  2012-09-19       Impact factor: 3.183

Review 5.  Prevalence of complementary medicine use in pediatric cancer: a systematic review.

Authors:  Felicity L Bishop; Philip Prescott; Yean Koon Chan; Jemma Saville; Erik von Elm; George T Lewith
Journal:  Pediatrics       Date:  2010-03-22       Impact factor: 7.124

Review 6.  Heterogeneity of coenzyme Q10 deficiency: patient study and literature review.

Authors:  Valentina Emmanuele; Luis C López; Luis López; Andres Berardo; Ali Naini; Saba Tadesse; Bing Wen; Erin D'Agostino; Martha Solomon; Salvatore DiMauro; Catarina Quinzii; Michio Hirano
Journal:  Arch Neurol       Date:  2012-08

7.  [The use of complementary and alternative medicine in children at a general paediatric clinic and parental reasons for use].

Authors:  A M Vlieger; E M van de Putte; H Hoeksma
Journal:  Ned Tijdschr Geneeskd       Date:  2006-03-18

Review 8.  Towards the harmonization of outcome measures in children with mitochondrial disorders.

Authors:  Saskia Koene; Merel Jansen; Chris M Verhaak; Remco L A De Vrueh; Imelda J M De Groot; Jan A M Smeitink
Journal:  Dev Med Child Neurol       Date:  2013-03-12       Impact factor: 5.449

9.  Use of complementary and alternative medicine by patients with lysosomal storage diseases.

Authors:  Manisha Balwani; Laura Fuerstman; Robert J Desnick; Brian Buckley; Margaret M McGovern
Journal:  Genet Med       Date:  2009-10       Impact factor: 8.822

10.  Trends in use of complementary and alternative medicine by US adults: 1997-2002.

Authors:  Hilary A Tindle; Roger B Davis; Russell S Phillips; David M Eisenberg
Journal:  Altern Ther Health Med       Date:  2005 Jan-Feb       Impact factor: 1.804

View more
  1 in total

1.  Adverse events associated with pediatric complementary and alternative medicine in the Netherlands: a national surveillance study.

Authors:  Björn Vos; Jan Peter Rake; Arine Vlieger
Journal:  Eur J Pediatr       Date:  2021-03-01       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.